Andere Sprachen Treace Medical Concepts, Inc.

Aktien

A3CM04

US89455T1097

TMCI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
10.67 ^USD	-1.75%		-6.40%	-16.31%

25.03.	Treace Medical Concepts behandelt 100.000 Patienten mit Lapiplastie-Ballenzeh-Korrektur	MT
27.02.	Transcript : Treace Medical Concepts, Inc., Q4 2023 Earnings Call, Feb 27, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour	24.04.
Treace to Present at Bank of America Health Care Conference	17.04.
Treace Announces First Annual National Bunion Day	16.04.
Treace to Report First Quarter 2024 Financial Results	09.04.
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	25.03.
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone	25.03.
Treace Medical Concepts: Q4 Earnings Snapshot	27.02.
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.02.
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	27.02.
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	27.02.
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27.02.
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance	27.02.
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results	07.02.
Treace Medical Concepts Says Post-Market Study of Lapiplasty Shows Patients Report 'Positive' Outcomes	02.02.
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure	02.02.
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	02.02.
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01.02.
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	01.02.
Treace Medical Concepts Expects Q4 Revenue of Up to $62 Million	08.01.
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	08.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Treace Medical Concepts, Inc.

Aktien

A3CM04

US89455T1097

TMCI

Andere Sprachen

Filter